A Phase 3, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety of Tramadol Infusion (AVE-901) in the Management of Post-Operative Pain Following Surgery
Phase of Trial: Phase III
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Tramadol (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Registrational
- Sponsors Avenue Therapeutics
- 02 Jan 2018 According to an Avenue Therapeutics media release, the first patients have been dosed in this trial. The results of this trial will support a new drug application (NDA), which the company expects to submit to the US FDA in late 2019.
- 02 Jan 2018 Status changed from planning to recruiting according to an Avenue Therapeutics media release.
- 20 Mar 2017 New trial record